Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Authors (first, second and last of 197)
Volume 16, issue 6, December 2014
43 articles in this issue
-
-
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Authors (first, second and last of 10)
-
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Authors (first, second and last of 210)
-
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis
Authors (first, second and last of 8)
-
Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
Authors (first, second and last of 8)
-
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells
Authors (first, second and last of 10)
-
Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
Authors (first, second and last of 11)
-
Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis
Authors (first, second and last of 8)
-
Outcomes of children exposed in uteroto chemotherapy for breast cancer
Authors (first, second and last of 10)
-
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women
Authors (first, second and last of 14)
-
DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression
Authors (first, second and last of 5)
-
Mammary cancer initiation and progression studied with magnetic resonance imaging
Authors (first, second and last of 10)
-
-
Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis
Authors (first, second and last of 4)
-
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
Authors (first, second and last of 9)
-
The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
Authors (first, second and last of 8)
-
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
Authors (first, second and last of 10)
-
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
Authors (first, second and last of 9)
-
-
E2F4 regulatory program predicts patient survival prognosis in breast cancer
Authors (first, second and last of 5)
-
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy
Authors (first, second and last of 9)
-
-
The role of androgens in experimental rodent mammary carcinogenesis
Authors (first, second and last of 6)
-
A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes
Authors (first, second and last of 12)
-
Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis
Authors (first, second and last of 6)
-
-
Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling
Authors (first, second and last of 12)
-
-
-
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes
Authors (first, second and last of 11)
-
Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes
Authors (first, second and last of 17)
-
MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration
Authors (first, second and last of 7)
-
The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress
Authors (first, second and last of 5)
-
-
Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays
Authors (first, second and last of 11)
-
A migrant study of pubertal timing and tempo in British-Bangladeshi girls at varying risk for breast cancer
Authors (first, second and last of 9)
-
-
-
Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer
Authors (first, second and last of 15)
-
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer
Authors (first, second and last of 7)
-
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial
Authors (first, second and last of 13)
-
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis
Authors (first, second and last of 11)
-
Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
Authors
